Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University

N. O Yuldasheva; Юлдашева Н. О; Regina I. Kunafina; Кунафина Р. И; D. D Sakaeva; Сакаева Д. Д; D. E Baikov; Байков Д. Э; R. R Suleymanova; Сулейманова Р. Р

doi:10.18565/pharmateca.2020.11.52-54

Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University

Autores: Yuldasheva N.O¹, Kunafina R.I.¹, Sakaeva D.D¹, Baikov D.E¹, Suleymanova R.R¹
Afiliações:
1. Bashkir State Medical University, BSMU Clinic
Edição: Volume 27, Nº 11 (2020)
Páginas: 52-54
Seção: Articles
URL: https://journals.eco-vector.com/2073-4034/article/view/312875
DOI: https://doi.org/10.18565/pharmateca.2020.11.52-54
ID: 312875

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Acesso é pago ou somente para assinantes

Resumo
Texto integral
Sobre autores
Bibliografia
Arquivos suplementares
Estatísticas

Resumo

Follow-up of oncological patients with coronavirus infection requires careful monitoring. Currently, there is no reliable national statistics on morbidity among patients with oncopathologies, as well as information on the features of the course of the disease. In our opinion, such an exchange of information is extremely important in order to properly organize work in the context of the COVID-19 pandemic.

Palavras-chave

coronavirus infection, viral pneumonia, oncological patients